Sivakesava Sakhamuri reports a stock award at CRSP
By AlphaYouPublished Form 4
Sakhamuri Sivakesava
Reporting filer
Sivakesava Sakhamuri reports a stock award, not an open-market purchase or sale, in CRISPR Therapeutics AG. Form 4 filed Nov 6, 2026 lists 2 entries.
- Disclosed
- Nov 6, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) (derivative) | Sakhamuri Sivakesava | 2026-11-04 | A | Grant or award | 90000 | 0 | 90,000 | 2 days | Filed terms
|
| Restricted Stock Units (derivative) | Sakhamuri Sivakesava | 2026-11-04 | A | Grant or award | 40000 | 0 | 40,000 | 2 days | Filed terms
|
Stock Option (Right to Buy) (derivative)
- Owner
- Sakhamuri Sivakesava
- Date
- 2026-11-04
- Code
- A
- Action
- Grant or award
- Quantity
- 90000
- Price
- 0
- Following holdings
- 90,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 51.78
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 90000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-04
- underlying Security Title: Common Shares
- underlying Security Shares: 90000
- shares Owned Following Transaction: 90000
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Sakhamuri Sivakesava
- Date
- 2026-11-04
- Code
- A
- Action
- Grant or award
- Quantity
- 40000
- Price
- 0
- Following holdings
- 40,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F2
- transaction Date: 2026-11-04
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 40000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- id: F3
- underlying Security Title: Common Shares
- underlying Security Shares: 40000
- shares Owned Following Transaction: 40000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sakhamuri Sivakesava: Chief Technical Officer.
- F1: This option was granted on November 4, 2026 with respect to 90,000 Common Shares. 25% of the shares shall vest on November 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter.
- F2: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- F3: This restricted stock unit award was granted on November 4, 2026 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on November 2, 2027, (ii) one quarter of the shares vesting on November 2, 2028, (iii) one quarter of the shares vesting on November 2, 2029, and (iv) one quarter of the shares vesting on November 2, 2030.
Original sources
Prepared automatically from public filing data. Report a correction.